The epidemic of obesity and diabetes is causing an increased incidence of dyslipidemia-related heart failure. While the primary etiology of lipotoxic cardiomyopathy is an elevation of lipid levels resulting from an imbalance in energy availability and expenditure, increasing evidence suggests a relationship between dysregulation of membrane phospholipid homeostasis and lipid-induced cardiomyopathy. In the present study, we report that the Drosophila easily shocked (eas) mutants that harbor a disturbance in phosphatidylethanolamine (PE) synthesis display tachycardia and defects in cardiac relaxation and are prone to developing cardiac arrest and fibrillation under stress. The eas mutant hearts exhibit elevated concentrations of triglycerides, suggestive of a metabolic, diabetic-like heart phenotype. Moreover, the low PE levels in eas flies mimic the effects of cholesterol deficiency in vertebrates by stimulating the Drosophila sterol regulatory element-binding protein (dSREBP) pathway. Significantly, cardiac-specific elevation of dSREBP signaling adversely affects heart function, reflecting the cardiac eas phenotype, whereas suppressing dSREBP or lipogenic target gene function in eas hearts rescues the cardiac hyperlipidemia and heart function disorders. These findings suggest that dysregulated phospholipid signaling that alters SREBP activity contributes to the progression of impaired heart function in flies and identifies a potential link to lipotoxic cardiac diseases in humans.
Obesity has reached global epidemic proportions in both adults and children and is associated with significant morbidity and mortality. Obesity and other factors such as diabetes, hypertension, and hyperlipidemia constitute a constellation of factors known as the metabolic syndrome that are known risk factors for coronary artery disease, which is the most common cause of heart failure in the United States (Schulze 2009 ). While it is well known that the metabolic syndrome contributes to atherosclerotic vascular diseases, emerging evidence suggests that it can also directly impact cardiac function independently of cardiovascular artherosclerosis. Under conditions of obesity and diabetes, dyslipidemia could lead to inappropriate accumulation of lipids in peripheral tissues such as the myocardium, resulting in organ malfunction, a process termed lipotoxicity. Various approaches have been undertaken to characterize the fundamental mechanisms underlying cardiac lipotoxicity in rodent models of obesity and diabetes and in transgenic mice with lipotoxic cardiomyopathy (Chiu et al. 2001 (Chiu et al. , 2005 Christoffersen et al. 2003; Yagyu et al. 2003; Son et al. 2007 ). These studies have helped in the understanding of how a mismatch between fatty acid and glucose uptake and use may result in increased deposition of free fatty acids and neutral lipids within the cardiomyocytes. This lipid overload could elicit the generation of detrimental lipotoxic metabolites that in turn induce cardiac dysfunction by multiple mechanisms, including the alteration of cellular signaling (Yang and Barouch 2007) , mitochondria dysfunction (Bugger and Abel 2008) , and lipoapoptosis (Unger and Orci 2002) .
While many studies on lipotoxicity in the heart focused on the pathogenesis of cardiomyopathy associated with lipid surpluses in lipid storage diseases such as obesity, an intriguing hypothesis for an alternative cause of lipotoxicity that has not been explored in detail in the heart is the relationship between altered membrane phospholipid homeostasis and lipid-induced cardiac dysfunction. A growing body of evidence is revealing the significance of impaired phospholipid-mediated signaling systems in cardiac hypertrophy, diabetic cardiomyopathy, and heart failure (Tappia and Singal 2008) , all of which could be associated with excessive cardiac lipid accumulation. In vitro studies have also supported this notion of an association between dysregulated phospholipid metabolism and cardiac lipotoxicity. For instance, a decreased synthesis of the signature mitochondrial membrane phospholipid cardiolipin corresponds with cytochrome c release in palmitate-induced cardiomyocyte apoptosis (Ostrander et al. 2001) . Moreover, free fatty acid overloading of cultured rat myocytes elicited phospholipid breakdown and culminated in cell death (Janero et al. 1988) . Last, but not least, it was found that a major cardioprotective effect of trimetazidine in rats was due to an increased synthesis of membrane phospholipids, which may direct a rebalancing of fatty acid use in the heart (Sentex et al. 1997 (Sentex et al. , 1998 . It was further proposed that the preservation of membrane phospholipid homeostasis could be considered as a therapeutic target in the treatment of heart failure (Tabbi-Anneni et al. 2003) . Clearly, it is important to investigate the functional roles of cellular phospholipids in cardiac steatosis and malfunction, and this would require the characterization of upstream mechanisms regulating the metabolism of phospholipids as well as the downstream phospholipidmediated signaling events.
Phosphatidylethanolamine (PE) is the second most abundant phospholipid in mammals (Leonardi et al. 2009 ) and the major phospholipid in most dipterans (Fast 1966) . The CDP-ethanolamine pathway is the principal route for PE synthesis in most mammalian tissues, with the first step requiring ethanolamine kinase (McMaster and Choy 1992) . In Drosophila, the easily shocked (eas)-encoded ethanolamine kinase catalyzes the phosphorylation of ethanolamine to phosphoethanolamine ( Fig. 1I ; Kennedy 1957) . Phosphoethanolamine is further modified by phosphoethanolamine cytidylytransferase (PECT) to produce CDP-ethanolamine, which, together with diacylglycerol (DAG), generates PE ( Fig. 1I ; Dobrosotskaya et al. 2002) . Consistent with its role in this pathway, the activity-null mutant of eas (eas 2 ) (Pavlidis et al. 1994) shows virtually no detectable ethanolamine kinase activity throughout development and exhibits a decrease in the level of PE (Pavlidis et al. 1994; Nyako et al. 2001) .
PE and its downstream signaling events appear to play a significant role in proper functioning of the heart, as seen by an alteration in the asymmetrical transbilayer distribution of PE in sarcolemmal membranes during ). Diastolic (red) and systolic (blue) intervals were indicated above each M-mode trace. n = number of female adult hearts. HP in A and B represents pooled 1-and 3-wkold data; HP in C and D represents 3-wkold data. (E,G) Bar graph representations of changes in HPs and heart chamber dimensions. P-values ([*] P < 0.05) were calculated using the Student's t-test. Error bars indicate SEM. Values for w 1118 and eas 2 represent pooled 1-and 3-wk-old data; values for others represent 3-wk-old data. (F,H,J) Representative confocal images of adult female hearts (anterior to left) stained with actinphalloidin (red). Arrows indicate similar regions of the cardiac vessel. (F-F0) The constricted heart tube in eas 2 (F9) is restored to wild-type size (F) by cardiac-targeted expression of Eas + (F0). (H) The eas 2 hearts exhibit significant loss and misarrangement of longitudinal and transverse myofibers (astericks). (I) Schematic overview of the various pathways of PE biosynthesis in eukaryotic cells. The scheme is modified from Dobrosotskaya et al. (2002) . Reprinted with permission from AAAS. Note that, in addition to the CDP-ethanolamine pathway (red), sphingolipids and other phospholipids such as phosphatidylserine can also feed into PE synthesis. Thus, eas deficiency only partially reduces PE levels. (J-J0) Hearts expressing RNAi constructs of pect and cept are considerably thinner than the control hearts.
ischemia, leading to sarcolemmal disruption (Post et al. 1995) . Moreover, abnormalities were found in the molecular species profile of PE that could contribute to membrane dysfunction and defective contractility of the diabetic heart (Vecchini et al. 2000) . Whereas many individual phospholipid constituents are known to be involved in specific signaling functions necessary for cells to respond to external stimuli, the specific signaling function of PE is largely unknown (Yao et al. 2009 ). From Drosophila tissue culture studies, it was postulated that PE could regulate the processing and hence signaling activity of the Drosophila sterol regulatory elementbinding protein (dSREBP) . The SREBPs comprise a subfamily of basic helix-loophelix leucine zipper transcription factors that are conserved global regulators of lipid homeostasis (Osborne and Espenshade 2009) . In response to various external stimuli, the precursor SREBP proteins are transported from the endoplasmic reticular (ER) membrane to the Golgi by the SCAP-Insig escort proteins, where they undergo proteolytic processing to release the transcriptional active domain, which translocates to the nucleus to induce cholesterol/lipogenic gene expression. Consistent with their critical roles in lipid synthesis, the aberrant activation of SREBPs could contribute to obesity-related pathophysiology in various organs, including cardiac arrhythmogenesis and hepatic insulin resistance (Shimano 2009 ).
In the present study, we explore the genetic-molecular links between dysregulated phospholipid metabolism and lipotoxic cardiomyopathy in the Drosophila eas 2 model. We discovered severe abnormalities in the cardiac physiology of adult eas 2 flies, with their hearts beating faster and exhibiting severe constriction akin to restrictive cardiomyopathy in humans. Under acute stress, the eas 2 mutant hearts succumb more frequently to arrest and fibrillation. These abnormalities are attributed to increased lipogenesis and triglyceride accumulation in the heart. The elevation in lipid concentrations in the eas 2 fly is caused by abnormal activation of the dSREBP pathway, most likely as a compensatory hyperactive response to constitutive deficiency in PE levels. Genetic manipulations to reduce the expression or activity of dSREBP in the eas 2 whole fly or heart lead to the rescue of the cardiac and lipid derangements. This study provides novel insight into the genetic relationship between phospholipid homeostasis and lipotoxic cardiomyopathy through the regulation of SREBP activity. The cardiac-autonomous role of SREBP in modulating heart function also identifies this component of phospholipid signaling as a candidate target for future therapies aimed at obesity-and diabetesrelated cardiac dysfunction.
Results

eas mutant flies exhibit defects in cardiac physiology
To identify candidate genes for cardiac function and aging, a heart performance screen in response to external electrical pacing ) was conducted using a random collection of Drosophila P-insertion lines, leading to the identification of eas as a candidate modulator of adult heart function (data not shown). We then examined the cardiac physiology of the activity-null fly mutant of eas (eas 2 ) using image-based assessment of heart function that combines high-speed optical recording of semi-intact adult preparations of beating (denervated) hearts with semiautomated analysis software for the quantification of heart function parameters (K Ocorr et al. 2007b; Fink et al. 2009 ). The video-captured M-modes of hearts revealed a significant reduction in the average heartbeat length (heart period [HP]) (see combined histograms in Fig. 1A,B ; Supplemental Tables S1, S2) of eas 2 as compared with wild-type (w 1118 ) (see the Materials and Methods). The shortened HP of eas 2 flies is due to decreased diastolic and systolic intervals (Fig.  1A ,B,E, red and blue lines above M-modes). Additionally, the eas 2 hearts are more constricted than wild-type hearts, as measured in live (Fig. 1G ) or fixed preparations ( Fig. 1F-F0 ). Because diastolic and systolic diameters seem to be reduced proportionally, eas 2 hearts do not show a change in fractional shortening, but the absolute volume output of the eas heart is dramatically reduced (by ;40%) (data not shown). In addition, the regular ventral longitudinal myofibrils of the heart are considerably disrupted in eas 2 hearts (Fig. 1H,H9 ). We further analyzed the heart contractile properties of eas
KG01772
, a P-element insertion in eas that results in less Eas + protein being produced as compared with wild-type (Supplemental Fig. S1A ). The transheterozygote of eas 2 and eas KG01772 also generates an increased tendency to have a faster heart rate (Supplemental Fig. S2A -C) as well as a significantly constricted heart tube (Supplemental Fig. S2D ), thereby partially phenocopying the eas 2 mutant heart defect. To determine if the cardiac abnormalities seen in the eas 2 fly is specific to eas, we attempted to re-express a wild-type Eas + cDNA in the hearts of eas 2 mutants using the cardiac-specific driver Hand-Gal4 (Supplemental Fig. S1B ). This significantly normalizes (''rescues'') the reduced HP of the eas 2 fly ( Fig. 1B-D ; Supplemental Table  S1 ), mainly by restoring the diastolic interval to normal levels (Fig. 1E ). In addition, the cardiac chamber also appears to regain normal size upon the overexpression of wild-type Eas + in the eas 2 hearts (Fig. 1F-F0) , with both the diastolic and systolic diameters evidently rescued to normal levels ( Fig. 1G ; Supplemental Table S1 ). Taken together, these results demonstrate that EAS function is critical for regulating normal heartbeat and contractility in a tissue-autonomous fashion.
Since eas encodes ethanolamine kinase involved in the biosynthesis of PE (Fig. 1I ), we asked whether the associated cardiac defects were due to insufficient PE synthesis through the CDP-ethanolamine pathway. Compared with control hearts (Fig. 1J) , the cardiac-specific expression of transgenic RNAi constructs against pect and cept both led to eas 2 -like heart tube constriction ( Fig. 1J9,J0 ; Supplemental Fig. S3C ) and a trend toward a faster heart rate (Supplemental Fig. S3A ,B; Supplemental Table S2 ), indicating that it is likely the cardiac dysregulation of PE metabolism that contributes to the eas heart derangements.
EAS function is required for proper heart performance under stress
In addition to its role in modulating cardiac physiology, EAS may also be involved in the maintenance of cardiac performance under conditions of acute stress, such as external electrical pacing-induced stress. In this stress test, heart performance is visually assessed by monitoring the incidence of cardiac arrest or fibrillation (termed ''heart failure'') . Adult heart response to pacing-induced stress is age-dependent and has been used as a measure of adult cardiac senescence . Upon being subjected to pacinginduced stress, the eas 2 flies exhibited elevated incidences of heart failure at both young (1 and 2 wk) and old (4 wk) ages, with failure rates of young eas 2 mutant hearts being comparable with old wild-type hearts ( Fig.  2A) . Expression of wild-type Eas + cDNA in eas 2 hearts is sufficient to rescue the stress-induced heart failure rates of eas 2 hearts to normal levels ( Fig. 2B ), demonstrating that tissue-autonomous loss of eas may elicit precocious and augmented cardiac aging. Moreover, when overexpressing Eas + in wild-type hearts, we found that heart performance under stress was improved even at young ages ( Fig. 2C ), implying that gain of EAS function is cardioprotective under stress.
Lipid metabolism is dysregulated upon perturbations in PE homeostasis
Several lines of evidence from tissue culture and murine studies have revealed a metabolic interconnection between the quantitatively most important phospholipids and triglycerides (TGs). Although phospholipids and TGs have different functions, these lipids are potentially subject to coregulation because they share common substrates and metabolic routes (Caviglia et al. 2004 ). Indeed, it was found that lipid intermediates released from phospholipids, such as DAG and fatty acids, can be used for TG synthesis (Vance 2008) , and there is limited evidence that shows that the disruption of PE synthesis in mice could led to increased formation of TGs (Fullerton et al. 2009; Leonardi et al. 2009 ). This prompted us to investigate the possibility that similar changes in TG and fatty acid metabolism could occur in the eas 2 fly in response to decreased PE synthesis. We first measured TG levels in wild-type control (w 1118 ) and eas 2 mutant flies that were aged for 1 wk after eclosion, and found that the eas 2 mutants exhibit a dramatic increase in TG levels (by nearly 50%) compared with control flies (Fig. 3A) . We also measured TG levels in eas 2 hearts and observed a similar elevation of TG levels over w 1118 control hearts (by ;20%) ( Fig. 3B) , suggesting that the eas 2 fly exhibits cardiac steatosis. Importantly, the global knockdown of pect and cept by RNAi also led to an increase in TG levels compared with control flies (Fig. 3C ), suggesting that hypertriglyceridemia in eas 2 is a consequence of defects in PE homeostasis.
Up-regulation of TG levels is generally associated with changes in fatty acid metabolism, with the three key enzymes that are required to divert glycolytic carbon flux into fatty acid biosynthesis being acetyl-coA carboxylase (ACC), ATP citrate lyase (ATPCL), and fatty acid synthase (FAS) (Shimano 2009 ). ATPCL converts cytosolic citrate into acetyl-CoA and oxaloacetate, thereby supplying the essential metabolite for lipid biosynthesis. Acetyl-CoA is in turn converted to malonyl-CoA by ACC before being used to generate long-chain fatty acids in a reaction catalyzed by FAS. We observed that the elevated TG levels in eas 2 flies and hearts are strongly suppressed upon reduced expression of genes encoding ACC and FAS by either the replacement of one functional copy of ACC with its mutant allele, ACC B131 , in the eas 2 background, or cardiac-specific RNAi knockdown of FAS (fas RNAi ) in the eas 2 mutant heart (Fig. 3A,B) . To further elucidate the potential roles of increased lipogenesis, increased uptake of fatty acids, or impaired degradation of lipids in contributing to hypertriglyceridemia in these flies, we examined the expression levels of ACC and ATPCL by Western blot analysis of whole-fly Figure 2 . eas 2 is required in a tissue-autonomous manner for proper heart performance under stress. (A) Cardiac failure rates of adult flies at different ages in response to pacing-induced stress. The eas 2 flies (blue) exhibit a higher frequency of cardiac failure at all ages when compared with same-aged wild-type (w 1118 ) flies (green). The failure rates of eas 2 flies at 1 and 2 wk old are similar to that of w 1118 flies at 4 wk old. About 60 flies were assayed per time point. (B) Cardiac failure rates in response to stress. Values represent pooled 1-and 2-wk-old failure rates. The high incidence of heart failure in eas 2 flies was rescued to normal levels (Hand-Gal4) upon cardiac expression of Eas + . About 60 flies were assayed per genotype. (C) Cardiac failure rates in response to stress. The rates of heart failure in GMH5-overexpressing Eas + hearts (green) is less pronounced in comparison with the respective driver (blue bar) and transgene controls (light blue). About 60 flies were assayed per genotype.
lysates. We observed enhanced expression levels of ACC and ATPCL in the eas 2 as well as global (Arm-G4-mediated) pect and cept knockdown (pect i and cept i ) flies relative to wild-type (w 1118 ) and control (Arm-G4) flies ( Fig. 3D,E ; see Supplemental Fig. S4 for ACC and ATPCL antibody specificity). These data indicate that a disruption of PE homeostasis in flies is associated with the stimulation of de novo lipogenesis, which facilitates the increased generation and accumulation of TG.
Altered lipid metabolism contributes to cardiac derangements in eas 2 flies
We next determined whether the increased production and accumulation of TGs may be responsible for the eas 2 heart disorders. To address this, we performed RNAimediated knockdown of lipogenic genes in either the heart or whole fly of eas 2 to ask whether they might alleviate cardiac disorders. The targeted expression of RNAi constructs against either ATPCL or FAS in the eas 2 hearts restored the heartbeat of the eas 2 fly (Fig. 4B ,H) to normal (Fig. 4C,D,I ,J). The constricted heart chamber phenotype in the eas 2 flies was also reversed to wild-type size in eas 2 flies with cardiac-targeted knockdown of ATPCL and FAS (Fig. 4M ). Similar observations were made in eas 2 flies that also contain a heterozygous deletion of either ACC or FAS (Fig. 4E ,F,K,L; Supplemental Fig. S5A ). The diastolic and systolic diameters of these flies were significantly restored as well ( Fig. 4N; Supplemental Fig.  S5B ). Taken together, these results indicate that reduced PE synthesis in the eas 2 fly stimulates fatty acid production and TG accumulation, which is accompanied by the development of cardiomyopathies that can be prevented by genetically counteracting lipid overloading.
Aberrant dSREBP signaling contributes to adiposity and cardiac deficits in eas 2 flies
Our data so far point toward an important interaction between PE and fatty acid/TG metabolism that seems to have a critical role in modulating adult heart function in flies. Although previous studies have demonstrated a link between PE homeostasis and TG metabolism that could play a significant role in the development of fatty liver and insulin resistance (Fullerton et al. 2009; Leonardi et al. 2009 ), the specific signaling and transcriptional pathway involved in mediating dyslipidemia and disease pathogenesis in response to deficient PE levels was not Figure 3 . Lipid metabolism is dysregulated in whole flies and hearts harboring perturbations in PE homeostasis. (A) TG levels were detected using a colorimetric lipid oxidase assay in 1-wk-old female flies (20-24 flies total). TG levels were normalized for average weight per fly and are presented as normalized to a wild-type level of 100%. Three independent experiments were performed for each genotype. All error bars are 6SD. (B) TG levels are determined using a colorimetric lipid oxidase assay in 1-wk-old female hearts (;20 hearts total). TG levels were normalized for total protein and are presented as normalized to a wild-type level of 100%. Compared with wild-type hearts (w 1118 ), the eas 2 and outcrossed eas 2 whole flies and hearts exhibit increased amounts of TGs, which were suppressed upon global and heart-specific suppression of dSREBP signaling and fatty acid synthetic enzyme expression. (C) TG levels were detected using a colorimetric lipid oxidase assay in 1-wk-old female flies (10-14 flies total). TG levels were normalized for average weight per fly and are presented as normalized to a wild-type level of 100%. Three independent experiments were performed for each genotype. All error bars are 6SD. Compared with the driver control flies (Arm-G4), flies that overexpress the RNAi construct of pect (Arm-G4>pectRNA firmly established. Our data show that the expression levels of ACC and FAS are up-regulated in flies harboring defects in PE synthesis (Fig. 3D-E) and may contribute to the observed cardiac derangements ( Fig. 4; Supplemental  Fig. S5 ). Both ACC and FAS were identified previously in tissue culture studies as being regulated by the dSREBP pathway Seegmiller et al. 2002) , suggesting that the dSREBP signaling pathway may be aberrant in these flies. Therefore, we tested the potential role of dSREBP in mediating the effects of an imbalance in PE metabolism on dyslipidemia and cardiac deficits in eas 2 flies. As a first step toward our goal, we determined whether dSREBP processing is altered in eas 2 mutants. In wildtype flies (Fig. 5A, lane 1) , endogenous dSREBP protein exists largely as a full-length, membrane-bound precursor (Fl-dSREBP), with small amounts detected as a cleaved, mature form (m-dSREBP). In contrast, eas 2 flies display a greater proportion of m-dSREBP relative to the fulllength protein (Fig. 5A, lane 2) than wild-type flies (Fig.  5A, lane 1) . Similarly, flies with global RNAi-mediated pect and cept knockdown (pect i and cept i ) also generate more m-dSREBP than controls (Fig. 5A, lanes 3-5) . Thus, our in vivo data validate the in vitro observations that a disruption of PE biosynthesis induces the processing of dSREBP , leading most likely to compensatory hyperactivation of dSREBP signaling in response to constitutively low levels of PE in the eas 2 fly . We next examined how alterations of dSREBP activity could influence heart performance. No obvious effects on heart function were observed upon cardiac-specific inhibition of dSREBP activity in young unstressed flies (data not shown), which was achieved via the cardiac-specific overexpression of a dominant-negative form of dSREBP (dSREBP DN75T ) (Porstmann et al. 2008 ). However, the cardiac overexpression of a constitutively active form of dSREBP (m-dSREBP (Porstmann et al. 2008 ) and a fulllength form of dSREBP (dSREBP FL ) (Porstmann et al. 2008 ) both led to a reduction in diastolic and systolic diameters as well as HP length relative to controls ( Table S2 ), reflecting the eas 2 cardiac defects (Fig. 1E,G) . Upon being subjected to pacing-induced stress, hearts that overexpress m-dSREBP underwent higher rates of failure compared with their respective controls at young ages (Fig.  5C ), indicative of compromised cardiac performance, similar to eas 2 hearts ( Fig. 2A) . Conversely, hearts that overexpress dSREBP DN75T show significantly lower rates of stress-induced cardiac dysfunction at an older age relative to the control hearts (Fig. 5D) , implying that the inhibition of dSREBP function augments cardiac resistance to stress at old age, which is reminiscent of the Eas + -overexpressing hearts (Fig. 2C) . These results, together with the increase in m-dSREBP protein in eas 2 mutants (Fig. 5A) , suggest that loss of eas and other perturbations resulting in PE deficiency triggers the elevated activation of dSREBP signaling, which is strongly associated with cardiac malfunction.
To test the above hypothesis further, we reduced dSREBP function in the eas 2 mutant context to determine if the severity of cardiac anomalies is ameliorated. A global reduction of dSREBP expression in the eas 2 fly was achieved by replacing one functional copy of dSREBP with its hypomorphic (dSREBP 52 ) counterpart (Kunte Fig. 5F -H,K-M). Moreover, the constricted heart diameters of eas 2 flies were restored to wild-type levels in eas 2 flies harboring dSREBP 52 heterozygosis ( Fig. 5O ; Supplemental Table  S1 ). Similar rescues of eas 2 cardiac defects were achieved with a null allele of dSREBP (dSREBP 189 ) (Kunte et al. 2006) in the eas 2 background (Supplemental Fig. S7 ; Supplemental Table S1 ). To further examine if up-regulation of dSREBP signaling contributes to the eas cardiac defects in a tissue-autonomous manner, we genetically suppressed the activity of dSREBP specifically in eas 2 hearts by cardiac-specific expression of dSREBP DN75T in eas 2 mutants ( Fig. 5 ; Supplemental Table S1 ). There is a significant restoration of both the faster heart rate and heart tube dimensions in those transgenic flies (Fig. 5I,N,P) . Finally, the improved cardiac parameters in eas 2 flies harboring reduced dSREBP expression (dSREBP 52 ) or activity (dSREBP DN75T ) are paralleled by a decrease in overall and cardiac accumulation of TG (Fig. 3A,B) . Taken together, these results demonstrate that the compensatory hyperactivation of dSREBP signaling in the eas 2 flies plays a causative role in inducing deterioration of heart function by generating a state of dyslipidemia. eas 2 hearts and hearts overexpressing m-dSREBP exhibit structural defects To further determine whether increased dSREBP signaling and lipogenesis in the eas 2 fly adversely affects the cytoarchitecture of the myocyte, we visualized myofibrils in the adult heartthat include densely packed transverse myofibrils in the myocardium and a layer of longitudinal muscle fibers associated with the ventral surface of the heart (Molina and Cripps 2001) . Compared with the wild type, the eas 2 hearts displayed severe degeneration and disorganization of the longitudinal and, to a lesser extent, inner transverse myofibrils (Figs. ) impeded the stress-induced decline in cardiac function in aged (4-wk-old) hearts. (E-N) Combined HP histograms and M-mode traces (2.5-sec traces) of pooled 1-and 3-wk-old female hearts (n = number of hearts). Diastolic (red) and systolic (blue) intervals are indicated above each M-mode trace. The evident decreases in the HPs of the eas 2 (F,K) and outcrossed eas 2 (G,L) hearts compared with wild-type hearts (E,J) were normalized upon the heterozygous loss of dSREBP (H,M) or heart expression of dominant-negative dSREBP (dSREBP DN75T ) in the eas 2 background (I,N). (O,P) Bar graph representations of changes in heart chamber dimensions. The diastolic and systolic diameters of 1-wk-old female eas 2 and outcrossed eas 2 hearts (light blue and green, O,P) were significantly reduced relative to wild-type (w 1118 ) hearts (blue, O,P), but were significantly restored upon the heterozygous loss of dSREBP (light green, O) or heart expression of dominant-negative dSREBP (dSREBP DN75T ) (light green, P) in the eas 2 background. P-values ([*] P < 0.05) were calculated using the Student's t-test. Error bars indicate SEM.
1H,H9, 6A-B9). The expression of wild-type Eas
+ cDNA, dSREBP DN75T , and fas RNAi (Fig. 6C-E9 ) in the eas 2 heart results in robust restoration of myofibrillar integrity, which includes the re-establishment of longitudinal myofibrils (Fig. 6C,D,E, arrows) . Of note, we were able to achieve substantial rescue of the eas 2 longitudinal myofibrils upon the expression of these constructs using Hand-Gal4, as this driver appears to be active only in the cardiomyocytes containing transverse myofibrils (see the Materials and Methods). Moreover, overexpression of m-dSREBP (activated form) in the heart using HandGal4 phenocopies the eas 2 mutation in the myocardium and causes significant loss of longitudinal fibers and disarrayed inner transverse myofibrils, compared with control hearts (Fig. 6F-G9 ). Taken together, these observations suggest that the structural alterations in the eas 2 hearts, like the functional deficits, are a consequence of a defect in PE homeostasis and elevation in dSREBP pathway and lipid synthesis. In addition, the genetic manipulations of cardiomyocytes may have significant non-cell-autonomous effects on the ventral muscle layer containing the longitudinal myofibrils. These longitudinal muscles are closely associated with the heart tube, and have been proposed to assist in circulation of the hemolymph through the heart tube (Molina and Cripps 2001) . It is therefore possible that the disposition of the cardiomyocytes influences the integrity of the longitudinal muscles such that abnormalities in them contribute to cardiac dysfunction in the eas 2 mutants. This interpretation is corroborated by previous studies in which genetic manipulations with cardiomyocyte-specific drivers also affect these longitudinal muscles (Birse et al. 2010; Neely et al. 2010) . In obese and diabetic rodent models and human subjects, myocardial steatosis correlates with functional and structural changes of the heart Harmancey et al. 2008) , which is consistent with our findings of eas 2 mutants. It has also been implicated that diabetes-induced changes in membrane phospholipid content and hydrolysis may contribute to some of the alterations in myocardial function that are observed in diabetic patients (McHowat et al. 2000; Su et al. 2005) . Drosophila eas could potentially serve as a useful model for exploring the cardiac effects of metabolic syndrome and type 2 diabetes.
Discussion
In this study, we used Drosophila genetic approaches to identify a novel metabolic cardiomyopathy that exhibits striking features of obesity-and diabetes-related heart failure in humans. Specifically, we showed that a genetically dysregulated phospholipid metabolism leads to chronic stimulation of the transcription factor dSREBP and its lipogenic target genes, which in turn leads to cardiac fat accumulation associated with electrical and functional signatures of heart failure. This study highlights a regulatory relationship between the PE phospholipid and TG metabolism that could play a major role in eliciting cardiac steatosis and dysfunction, and identifies the dSREBP signaling pathway as the key metabolic pathway that underlies the increased synthesis and accumulation of TG upon the disruption of PE homeostasis.
Our current data led us to put forth a model (Fig. 7) that describes how the dysregulation of membrane PE homeostasis could promote the pathogenesis of lipotoxic cardiomyopathy. In wild-type flies, a decrease in membrane PE level triggers the proteolytic release of a transcriptionally active form of dSREBP (m-dSREBP) and induces the biosynthesis of fatty acids in a manner similar to that in mammals (Nohturfft and Losick 2002; see also above) . Upon the subsequent use of these fatty acids in PE synthesis, and the restoration of normal PE concentrations in cellular membranes, further processing of dSREBP is blocked and overall lipid synthesis is reduced. The presence of such a feedback inhibitory loop ensures that PE homeostasis can be achieved under physiological conditions. In flies harboring a genetic perturbation of the CDPethanolamine pathway, the failure to produce PE and the ensuing low levels of PE disrupt the homeostatic negative feedback loop, resulting in the continuous activation of the dSREBP pathway. Prolonged stimulation of lipogenesis and the oversupply of lipid intermediates such as acyl coA and DAG could lead to increased production of TG, resulting in hypertriglyceridemia, cardiac steatosis, and the progressive development of lipotoxic cardiomyopathy.
It is possible that the above phenomenon, although identified in a fly model, also occurs in mammals. In fact, in mice, elimination of the CDP-ethanolamine pathway resulting in the absence of PE synthesis induced a significant elevation of TG levels (Fullerton et al. 2009; Leonardi et al. 2009 ). Along with hypertriglyceridemia, it was also observed in these studies that the expression of key fatty acid biosynthetic genes such as ACC and FAS is up-regulated in PE-deficient mice. It has been proposed that the elevated TG concentration is due to an increased availability of DAG arising from its underutilization by the CDP-ethanolamine pathway that leads to a redirection of DAG to TG formation (see Fig. 7 ; Fullerton et al. 2009; Leonardi et al. 2009 ). However, this proposal fails to explain how the passive accumulation of DAG in the PE-deprived state could induce an upstream event such as the expression of the lipogenic genes (see Fig. 7 ). The mechanism proposed in our model based on the eas 2 fly studies could reconcile to some extent this dilemma in the mammalian system. Our model posits that constitutively low levels of PE drive a compensatory hyperactivation of the SREBP pathway. Once activated, SREBP can induce de novo lipogenesis and the active generation of intermediates such as acyl coA and DAG, a sequence of steps that culminates in the heightened production of TG (Fig. 7) . Indeed, in mice lacking the capacity to generate PE, the expression of one of the mammalian SREBP isoforms, SREBP-1c, was found to be up-regulated (Fullerton et al. 2009; Leonardi et al. 2009 ). Furthermore, the PE-deficient mice also develop metabolic disorders such as hepatic steatosis and insulin resistance (Fullerton et al. 2009; Leonardi et al. 2009 ). However, it remains to be seen whether SREBP signaling might similarly be regulated by PE homeostasis in mammals such that a deficit in PE levels elicits an activation of the SREBP pathway to generate increased amounts of fatty acids and DAG/TG. It would be interesting to test whether the enhanced levels of TGs, as well as the severity of these phenotypes, would be significantly ameliorated upon the down-regulation of SREBP expression or activity in these mice, indicating a primary role of SREBP signaling in mediating the development of hypertriglyceridemia and its related metabolic disorders upon the perturbation of PE synthesis in the mammalian context.
Concluding remarks
Our model, based on studies in Drosophila eas mutants, provides insights into the potential role of the dSREBP signaling pathway in coupling membrane phospholipid homeostasis with lipid metabolism and its associated metabolic functions. Our findings also support the notion that Drosophila shares many of the basic metabolic functions found in vertebrates (Baker and Thummel 2007) , and that the genetic dissection of the metabolic and transcriptional responses in a less complex model organism such as Drosophila facilitates our understanding of fundamental aspects of metabolic control, cardiac physiology, and associated disease mechanisms.
Materials and methods
Fly stocks
Drosophila strains were maintained on standard cornmealmolasses agar medium at room temperature (22°C-25°C). The eas gene is located at 14B on the cytological map and encodes an ethanolamine kinase (Pavlidis et al. 1994) . The eas allele used in this study is eas 2 (also known as eas PC80 ), provided by M. Tanouye (University of California at Berkeley). It is caused by a 2-base-pair (bp) deletion that introduces a frame shift; the resulting truncated protein lacks a kinase domain and abolishes all enzymatic activity. The w 1118 , eas alaP allele was induced by P(GawB) mutagenesis (Boquet et al. 2000) , and was obtained from Thomas Preat (CNRS, France). The eas KG01772 , ACC B131 , and FAS KG3696 alleles were received from the Bloomington Stock Center. The myocardial-specific GAL4 drivers were Hand-Gal4 (generous gift from L. Perrin). Hand-Gal4 was found to be expressed in myocardial cells but not in the muscle cells containing the longitudinal fibers. This is in agreement what was reported previously by Han et al. (2006) and Togel et al. (2008) for Hand-Gal4 constructs. GMH5 was described previously 
Antibodies
Anti-EAS (Pascual et al. 2005 ) (a gift from Thomas Preat) and anti-a-tubulin (B-5-1-2, Sigma) were used for immunoblot analyses. The anti-human IgG-2A4 SREBP-1 antibody was purchased from BD Biosciences, and was used at 1:1000 for immunoblotting. This monoclonal antibody was raised against amino acid residues 301-407 in human SREBP-1a and has been shown previously to cross-react with dSREBP (Theopold et al. 1996; Rosenfeld and Osborne 1998) . The anti-human ACC antibody (#3662) and anti-human ATPCL antibody (#4332) were purchased from Cell Signaling Technology, Inc.. The cross-reactivities of these human antibodies against Drosophila ACC and ATPCL proteins were determined by the following: First, immunoblot analysis of wild-type fly lysates using these two antibodies revealed bands that correspond to the predicted sizes of Drosophila ACC and ATPCL proteins (Supplemental Fig. S4) . Second, immunoblot analysis of the ACC B131/+ fly lysate using the antihuman ACC antibody revealed a significant diminution of the predicted ACC band, as did the predicted ATPCL band upon immunoblot analysis of the ATPCL 23402 fly lysates using antihuman ATPCL antibody (Supplemental Fig. S4 ). Note that the ATPCL band in the w 1118 lane in Figure S4A has been subjected to longer exposure than the ATPCL band in the w 1118 lane in Figure  3D9 . Third, the anti-human ACC antibody is predicted to crossreact with Drosophila ACC based on 100% sequence homology with the residues surrounding Lys 557 of human ACCa1 (Cell Signaling, #3662 product sheet). For immunostaining purposes, fluorescein-labeled phalloidin (Invitrogen) and mouse anti-actinin (Saide et al. 1989) were used.
Immunostaining
Adult female flies (7-10 d old) were dissected to expose the heart and were fixed for 15 min in 4% paraformaldehyde. After washing in PBS plus 0.1% Triton X-100 (PBT-0.1), the fixed hearts were incubated overnight at 4°C with primary antibodies appropriately diluted in PBT-0.1. The tissues were then washed with PBT-0.1 and incubated with fluorescence-conjugated secondary antibodies. The following antibodies were used at the concentrations indicated: mouse anti-a-actinin (1:20) and fluoresceinlabeled phalloidin (1:20). Secondary antibodies were FITC-conjugated anti-mouse and Cy3-conjugated anti-rabbit IgG (Sigma). Samples were mounted in VectaShield (Vector Laboratories). Images were acquired on an MRC 1024 SP Bio-Rad laser point scanning confocal microscope using LaserSharp 2000 software (Bio-Rad). Consecutive confocal sections were acquired in the Z-axis with a step of 2 mm and were projected in ImageJ software.
Immunoblotting
For whole adult protein analysis of Eas, ACC, and ATPCL, 7-to 10-d-old female flies were homogenized in cell lysis buffer (PBT-0.1) supplemented with a cocktail of protease inhibitors. For whole adult protein analysis of dSREBP, flies were homogenized in buffer F (125 mM Tris-HCl at pH 6.8, 8 M urea, 5% SDS) supplemented with a cocktail of protease inhibitors (Matthews et al. 2010 ). Lysates were clarified by centrifugation, boiled in 13 SDS sample buffer, resolved by SDS-PAGE, transferred onto PVDF membranes, and probed with the relevant antibodies as described above. Chemiluminescence was detected using ECL Plus Western blotting detection reagents (Amersham).
TG measurement
For quantification of TGs in whole flies, crude lysates of 10 adult female flies (7-10 d old) in lysis buffer PBT-0.05 (PBS plus 0.05% Triton X-100) were prepared by homogenization or sonication. For quantification of TGs in hearts, 20-25 adult female hearts (7-10 d old) were lysed in PBT by brief sonication. TG amounts were measured using Infinity Triglycerides assay kit (Thermo Electron Scientific, catalog no. TR22421) according to manufacturer's instructions, and were normalized to protein amounts measured by the Bio-Rad protein assay kit (Bio-Rad).
Fly heartbeat analysis
To measure cardiac function parameters, a semi-intact preparation of fly heart was analyzed according to previously described protocols (K Ocorr et al. 2007a,b; Ocorr et al. 2009 ). High-speed 30-to 60-sec movies were taken at a rate of >100 frames per second using a Hamamatsu CCD camera on a Leica DM LFSA microscope with a 103 dipping immersion lens. The images were processed using Simple PCI imaging software (Compix, Inc.). M-modes and quantitative data were generated using a MatLab-based image analysis program (K Ocorr et al. 2007a,b; Ocorr et al. 2009 ). Briefly, to generate M-mode figures, a singlepixel-wide column that encompasses both edges of the heart tube was selected, and corresponding columns were cut from all movie frames and aligned horizontally according to time. Thus, the M-mode provides an edge trace that documents the movement of the heart tube walls in the Y-axis over time in the X-axis. HPs are defined as the time between the ends of two consecutive diastolic intervals. Diastolic interval is the time taken for the heart to relax, and systolic interval is the time taken for the heart to contract. Diastolic diameter is the diameter of the opposing heart wall during a period of relaxation; systolic diameter is the diameter of the opposing heart wall during a period of constriction. Measurements for the diastolic and systolic diameters were taken from the most posterior portion of the heart at the abdominal A3 segment (region of the valve). Only female hearts were analyzed in this study.
Electrical pacing
To measure adult heart response to external electrical pacing, intact fly hearts were analyzed according to previously described protocols (Wessells et al. , 2009 KA Ocorr et al. 2007) . Briefly, eight to 10 female flies were placed between two electrodes touching conductive jelly spread over the electrodes. Their hearts were paced with a square wave stimulator at 40 V and 6 Hz for 30 sec. Hearts were visually scored between 60 and 90 sec after pacing for signs of arrest or fibrillation. Heart failure rate is defined as the percentage of flies that enter either cardiac arrest or fibrillation.
